DE1569231A1 - Adhesive - Google Patents
AdhesiveInfo
- Publication number
- DE1569231A1 DE1569231A1 DE19641569231 DE1569231A DE1569231A1 DE 1569231 A1 DE1569231 A1 DE 1569231A1 DE 19641569231 DE19641569231 DE 19641569231 DE 1569231 A DE1569231 A DE 1569231A DE 1569231 A1 DE1569231 A1 DE 1569231A1
- Authority
- DE
- Germany
- Prior art keywords
- adhesive
- mixture
- polyisobutylene
- rubber
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001070 adhesive effect Effects 0.000 title claims description 43
- 239000000853 adhesive Substances 0.000 title claims description 41
- 229920002367 Polyisobutene Polymers 0.000 claims description 24
- -1 glycerin ester Chemical class 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 9
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 9
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 9
- 239000000416 hydrocolloid Substances 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
- 229920001971 elastomer Polymers 0.000 claims description 6
- 239000002480 mineral oil Substances 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 5
- 235000010446 mineral oil Nutrition 0.000 claims description 5
- 244000043261 Hevea brasiliensis Species 0.000 claims description 4
- 229920003052 natural elastomer Polymers 0.000 claims description 4
- 229920001194 natural rubber Polymers 0.000 claims description 4
- 150000003097 polyterpenes Chemical class 0.000 claims description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 239000004705 High-molecular-weight polyethylene Substances 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229940072049 amyl acetate Drugs 0.000 claims description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 229940096529 carboxypolymethylene Drugs 0.000 claims description 2
- 150000008282 halocarbons Chemical class 0.000 claims description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920003225 polyurethane elastomer Polymers 0.000 claims description 2
- 229920002379 silicone rubber Polymers 0.000 claims description 2
- 239000004945 silicone rubber Substances 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 239000001828 Gelatine Substances 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 1
- QXNIBPDSSDVBQP-UHFFFAOYSA-N acetic acid;2-methylpropanoic acid Chemical compound CC(O)=O.CC(C)C(O)=O QXNIBPDSSDVBQP-UHFFFAOYSA-N 0.000 claims 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 claims 1
- 235000011187 glycerol Nutrition 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 235000015424 sodium Nutrition 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- 239000004698 Polyethylene Substances 0.000 description 7
- 229920000573 polyethylene Polymers 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229920000084 Gum arabic Polymers 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000000205 acacia gum Substances 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 229920001084 poly(chloroprene) Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003566 sealing material Substances 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- UVGUPMLLGBCFEJ-SWTLDUCYSA-N sucrose acetate isobutyrate Chemical compound CC(C)C(=O)O[C@H]1[C@H](OC(=O)C(C)C)[C@@H](COC(=O)C(C)C)O[C@@]1(COC(C)=O)O[C@@H]1[C@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@H](OC(=O)C(C)C)[C@@H](COC(C)=O)O1 UVGUPMLLGBCFEJ-SWTLDUCYSA-N 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ZXUJWPHOPHHZLR-UHFFFAOYSA-N 1,1,1-trichloro-2-fluoroethane Chemical compound FCC(Cl)(Cl)Cl ZXUJWPHOPHHZLR-UHFFFAOYSA-N 0.000 description 1
- WDRCPKDLZOQCFU-UHFFFAOYSA-N 2-methyl-n-phenylpropanamide Chemical compound CC(C)C(=O)NC1=CC=CC=C1 WDRCPKDLZOQCFU-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930183010 Amphotericin Natural products 0.000 description 1
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 229940009444 amphotericin Drugs 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- IJAQKRMEHJVIDI-UHFFFAOYSA-N methyl 1-hydroxycyclohexa-2,4-diene-1-carboxylate Chemical compound COC(=O)C1(O)CC=CC=C1 IJAQKRMEHJVIDI-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000001797 sucrose acetate isobutyrate Substances 0.000 description 1
- 235000010983 sucrose acetate isobutyrate Nutrition 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- KMIOJWCYOHBUJS-HAKPAVFJSA-N vorolanib Chemical compound C1N(C(=O)N(C)C)CC[C@@H]1NC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C KMIOJWCYOHBUJS-HAKPAVFJSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/30—Rubbers or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
- A61L15/585—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Description
DR. ELISABETH JUNG. DR. VOLKER VOSSIUS1 DIPL.-ING. GERHARD COLDEWEYDR. ELISABETH JUNG. DR. VOLKER VOSSIUS 1 DIPL.-ING. GERHARD COLDEWEY
P 15 69 251*6P 15 69 251 * 6
(0 10 388 lVo/39b)(0 10 388 lVo / 39b)
U.Z.& 516 (Be/vo)UZ & 516 (Be / vo)
USSN 310 162
330 271USSN 310 162
330 271
E.R.SQUIBB <fc SONS, INCo New York, H-Y., V.St.A·'E.R.SQUIBB <fc SONS, INCo New York, H-Y., V.St.A. '
"Klebmasse""Adhesive"
Die Erfindung betrifft eine Klebmasse <> Insbesondere betrifft die Erfindung eine druckempfindliche Klebmasse, die gegebenenfalls zusammen mit organischen Lösungsmitteln für das'Verkleben oder Abdichten von nassen Flächen wie Papier, Holz, Tuch, Rohren, Lecks in Booten oder Särperflächen verwendet werden kann*The invention relates to an adhesive <> In particular, the invention relates to a pressure-sensitive adhesive, which may be used together with organic solvents for gluing or sealing wet surfaces such as Paper, wood, cloth, pipes, leaks in boats or coffin surfaces can be used*
Ein' Nachteil bekannter druckempfindlicher Klebmassen besteht darin, dass sie nicht auf nassen Flächen haften» Werden solche Klebmasaen auf Flächen aufgetragen, die an» schliessend mit Wasser in Berührung kommen, so gehen Sie Klebeigenschaften verloren, wenn die Flächen feucht werden.There is one disadvantage of known pressure-sensitive adhesives in that they do not adhere to wet surfaces. finally come into contact with water, so go Adhesive properties are lost when the surfaces become damp.
Es wurde eine neue Klebmasse gefunden, die sofort auf den verschiedenartigster«, nassen Flächen haftet und ihr® Klebeigenschaften nicht verliert, wenn mit der Klebmasse behaftete trockene Flächen feucht werden.A new adhesive was found that immediately applied to the a wide variety of «wet surfaces and their® adhesive properties does not lose when stuck with the adhesive dry surfaces become damp.
909834/1297909834/1297
Neue UmeNew ume
Die erfindungsgemässe Klebmasse ist gekennzeichnet durch einen Gehalt an einem wasserlöslichen oder quellfähigen Hydrokolloid oder einer Mischung solcher Hydrokolloide im Gemisch mit einem wasserunlöslichen, viskosen ,kautsehuk- «rfcigen Bindemittel» Das Hydrokolloid ist z.B. Polyvinylalkohol, gepulvertes Pektin, Gummiarabicum, Gelatine, ein Alginat oder Carraghenat, Carboxymethylcellulose, hochmolekulare Polyäthylenglykole und Methoxypolyäthylenglykole (Oarbowax), Carboxypolymethylene, Polyoxyäthylene und ähnliche Substanzen. Als Bindemittel werden viskose wasserunlösliche, natürliche oder synthetische kautschukähnliche Stoffe verwendet, wie Polyisobutylen oder Saccharoseacetatisobutylat oder ein Elastomerengemisch wie Naturkautschuk, Siliconkautschuk, Acrylnitrilkautschuk, Polyurethankautschuk und Gemische solcher Stoffe, zu denen vorzugsweise ein Mittel zum Klebrigmachen, wie ein Kolophoniumharz, ein Polyterpenharz, ein Glycerinester von hydriertem Kolophonium oder ein Pentaerythritester von hydriertem Kolophonium zu-' gesetzt ist. Die viskose, kautschuk- oder pflanzenschleimähnliche Substanz wirkt als Klebemittel, das an trockenen Flächen haftet sowie als Bindemittel für die Hydrokolloidteile und macht die fertige Klebmasse elastisch und geschmeidig. The adhesive according to the invention is characterized by a content of a water-soluble or swellable hydrocolloid or a mixture of such hydrocolloids mixed with a water-insoluble, viscous , chewy-chewy binder. The hydrocolloid is, for example, polyvinyl alcohol, powdered pectin, gum arabic, gelatin, an alginate or carraghenate , Carboxymethyl cellulose, high molecular weight polyethylene glycols and methoxypolyethylene glycols (Oarbowax), carboxypolymethylene, polyoxyethylene and similar substances. The binders used are viscous, water-insoluble, natural or synthetic rubber-like substances, such as polyisobutylene or sucrose acetate isobutylate or an elastomer mixture such as natural rubber, silicone rubber, acrylonitrile rubber, polyurethane rubber and mixtures of such substances, which preferably include a tackifier, such as a rosin resin, such as a colophony resin of hydrogenated rosin or a pentaerythritol ester of hydrogenated rosin is added. The viscous, rubber or plant slime-like substance acts as an adhesive that adheres to dry surfaces and as a binding agent for the hydrocolloid parts and makes the finished adhesive elastic and pliable.
Ausser den genannten Bestandteilen können der Klebmasse verschiedene organische Lösungsmittel oder Weichmacher zugesetzt werden, um die Hafteigenschaften zu verbessern und/oder die gewünschte Konsistenz zu liefern. Als derartige Lösungsmittel kommen z.B. Chloroform, verschiedene Halogenkohlenwasserstoffe (Trichlormonofluormethan, Difluordichlormethan, CClP2 - OClPg' Methylenchlorid), Schwefelkohlenstoff und verschiedene Ester wie Amylacetat in Frage. Als Weichmacher können den Klebmassen Mineralöle, Vaseline (Petrolatum) und ähnliche Stoffe zugesetzt werden.In addition to the constituents mentioned, various organic solvents or plasticizers can be added to the adhesive in order to improve the adhesive properties and / or to provide the desired consistency. Such solvents are, for example, chloroform, various halogenated hydrocarbons (trichloromonofluoromethane, difluorodichloromethane, CClP 2 - OClPg 'methylene chloride), carbon disulfide and various esters such as amyl acetate. Mineral oils, petrolatum (petrolatum) and similar substances can be added to the adhesives as plasticizers.
909834/1297909834/1297
BAD ORJGfHAiBAD ORJGfHAi
Ein Gemisch aus Polyisobutylen und darin einverleibter Natriumcarboxymethyloellulose liefert, wie festgestellt wurde, hervorragende Ergebnisse und ist daher bevorzugt. In den Fällen, in denen ein klarer Klebstoff erwünscht ist, zeigte sich ein Gemisch aus Polyisobutylen und einem PoIyoxyäthylen mit hohem Molekulargewicht hervorragend geeignet. In Kombination mit diesen bevorzugten Klebmassen kann ein Gemisch aus Mineralöl als Weichmacher und Chloroform oder Kethylenohlorid als Lösungsmittel vorzugsweise verwendet werden.A mixture of polyisobutylene and those incorporated therein Sodium Carboxymethyloellulose supplies as stated has produced excellent results and is therefore preferred. In those cases where a clear adhesive is desired, A mixture of polyisobutylene and a polyoxyethylene with a high molecular weight was found to be extremely suitable. In combination with these preferred adhesives, a mixture of mineral oil as plasticizer and chloroform or Kethylene chloride can preferably be used as a solvent.
Die erfindungsgemässen Klebmassen können als solche für Klebüberzüge nach Verdampfen des Lösungsmittels oder auf Trägern,wie Papier, Celluloseregeneratfolie (Zellglas) aus dialysierbarem oder mit anderen Polymeren wie Polyäthylen beschichtetem Celluloseregenerat und auf verschiedenen Kunststoffen, wie Polyvinylidenchloridfolie oder Folien aus Fluorhalogenkoh lenwasserst of f polymeren, aufgebracht verwendet werden.The adhesives according to the invention can be used as such for Adhesive coatings after evaporation of the solvent or on carriers such as paper, regenerated cellulose film (cell glass) cellulose regenerated material which can be dialysed or is coated with other polymers such as polyethylene and is applied to various plastics such as polyvinylidene chloride film or films made of fluoride halogenated hydrocarbons will.
Wenn die erfindungsgemässen Klebmassen auf einem bandförmigen Streifen aufgebracht sind, können sie beispielsweise als zeitweiliges Dichtungsmaterial, z.B. für Lecks in Booten und Schiffen oder Rohrleitungen, oder für Verbände für feuchte Körperflächen verwendet werden, die sich nicht durch Schweigst bildung, beim Schwimmen oder Baden ablösen. Sie sind daher besonders geeignet für Verbandpflaster z.B. für Sportler. In der Veterinärmedizin können derartige Klebstreifen beispielsweise ale Verbände für Fische und im Wasser lebende Säugetiere verwendet werden. Die erfindungsgemässen Klebmassen können auch als Klebstoff für Binden verwendet werden, die für Bäume oder andere Pflanzenarten gebraucht werden, die Feuchtigkeit ausgesetzt sind. Sie können ebenfalls als Klebstoff für Etiketten auf sehr feuchten Flächen, z.B. in Kühlschränken und Tiefkühlanlagen gebraucht werden.If the adhesives according to the invention are applied to a tape-shaped strip, they can, for example as temporary sealing material, e.g. for leaks in boats and ships or pipelines, or for bandages for damp Areas of the body are used that are not covered by silence education, peel off when swimming or bathing. They are therefore particularly suitable for bandages, e.g. for athletes. In veterinary medicine, such adhesive strips can be used, for example, as dressings for fish and those living in the water Mammals are used. The adhesives according to the invention can also be used as adhesives for bindings, that are used for trees or other plant species that are exposed to moisture. You can also use it as a Adhesives are used for labels on very damp surfaces, e.g. in refrigerators and freezers.
909834/1297909834/1297
In Kombination mit einem Lösungsmittel zur Viskositäteez»- niedrigung können die erfindungSgemäaeen Klebmasβen in verschiedener Form vorliegen, die sie zur Verwendung z.B. mit Auftragewalzen, in mechanischen Spritzgeräten und als Aerosole geeignet machen.In combination with a solvent to reduce viscosity »- The adhesive compositions according to the invention can be present in various forms that they can be used with, for example Make applicator rollers, in mechanical spray equipment and as aerosols suitable.
Gegebenenfalls können Arzneistoffe wie Insulin, Antibiotika, z.B. Amphotericin und Tetracyclin, Anästhetika wie Benzooain, entzündungshemmende Mittel wie Triamcinolonacetonid oder Natriumfluorid zur Kariesbehandlung in die Klebmassen gemäss der Erfindung eingearbeitet oder auf diese auf der Berührungsfläche mit den zu behandelnden Hautteilen oder Pflanzenteilen aufgestäubt, aufgespritzt oder ausgebreitet werden.If necessary, drugs such as insulin, antibiotics, e.g. amphotericin and tetracycline, anesthetics such as benzoain, anti-inflammatory agents such as triamcinolone acetonide or sodium fluoride for the treatment of caries in the adhesives according to of the invention incorporated or on this on the contact surface with the parts of the skin or parts of plants to be treated dusted, sprayed or spread.
Die Erfindung wird durch die folgenden Beispiele näher erläutert.The invention is illustrated in more detail by the following examples.
58 g Polyisobutylen werden auf 70 bis 80° C erhitzt» Man vermischt 42 g Natriumcarboxymethylcellulosepulver mit dem erhitzten Polyisobutylen und lässt die Misohung abkühlen. Dabei bildet sich eine teigartige Masse, die zur gleichmassigeren Vermischung auf eine Mischwalze gegeben wird, und dann in einer hydraulischen Presse zu der gewünschten Dicke ausgepresst wird. Man presst dann auf eine Seite eine dünne Polyäthylenfolie und schneidet den erhaltenen Schichtstoff in Streifen, Vierecke oder andere formen der gewünschten GrÖBse.58 g of polyisobutylene are heated to 70 to 80 ° C »Man mixed 42 g of sodium carboxymethyl cellulose powder with the heated polyisobutylene and let the mixture cool down. A dough-like mass is formed, which is placed on a mixing roller for more even mixing, and then pressed in a hydraulic press to the desired thickness. You then press a thin one on one side Polyethylene film and cut the resulting laminate into strips, squares or other shapes of the desired Size.
Das in Beispiel 1 beschriebene Verfahren wird wiederholt, jedoch werden die 58 g Polyisobutylen durch eine Misohung von 56 g Polyisobutylen und 2 g Vaseline ersetzt. Man erhält auch hier einen befriedigenden Verband.The procedure described in Example 1 is repeated, however, the 58 g of polyisobutylene are replaced by a mixture of 56 g of polyisobutylene and 2 g of Vaseline. Here, too, a satisfactory association is obtained.
909834/1297909834/1297
Das in Beispiel 1 beschriebene Verfahren wird wiederholt, jedoch werden die 58 g Polyisobutylen durch eine Mischung von 55 g Polyisobutylen und 1 g auf 70 bis 80° C vorgewärmtes Mineralöl ersetzt. Man erhält auch hier einen befriedigenden Verband.The procedure described in Example 1 is repeated, however, the 58 grams of polyisobutylene are made by a blend replaced by 55 g of polyisobutylene and 1 g of mineral oil preheated to 70 to 80 ° C. Here, too, you get a satisfactory one Association.
Das in Beispiel 1 beschriebene Verfahren wird wiederholt, jedoch werden die 42 g Natriumoarboxymethylcellulose durch 42 g fein gepulverten Polyvinylalkohol ersetzt·The procedure described in Example 1 is repeated, however, the 42 g of sodium arboxymethyl cellulose gets through 42 g of finely powdered polyvinyl alcohol replaces
Das in Beispiel 1 beschriebene Verfahren wird wiederholt, jedoch wird die Natriumcs-rboxymethylcellulose durch 42 g Gummiarabicum ersetzt.The procedure described in Example 1 is repeated, but the sodium c-rboxymethyl cellulose is replaced by 42 g Gum arabic replaced.
Das in Beispiel 1 beschriebene Verfahren wird wiederholt, jedoch verwendet man eine Mischung von 30 g Gummiarabicum und 12 g einer gepulverten Mischung von Gelatine, Pektin und Natriumcarboxymethyloellulose und erhält damit einen befriedigenden Verband.The procedure described in Example 1 is repeated, but using a mixture of 30 g of gum arabic and 12 g of a powdered mixture of gelatin, pectin and sodium carboxymethyloellulose, thus obtaining a satisfactory one Association.
Das in Beispiell 1 beschriebene Verfahren wird wiederholt, jedoch vereinigt man vor der Zugabe zum Polyisobutylen 37 g Natriumcarboxymethyloellulose mit 5 g p-Aminqbenzoesäureäthylester, um einen Medikamentverband zu erhalten.The procedure described in Example 1 is repeated however, 37 g are combined before addition to the polyisobutylene Sodium carboxymethyloellulose with 5 g of ethyl p-aminobenzoate, to get a drug bandage.
Das in Beispiel 1 beschriebenen Verfahren wird wiederholt, jedoch verwendet man anstelle von 42 g Natriumcarboxymethyloellulose 38 g dieser Verbindung, 3 g Amphotericin B und 1 g The process described in Example 1 is repeated, but instead of 42 g of sodium carboxymethyloellulose, 38 g of this compound, 3 g of amphotericin B and 1 g are used
909834/1297909834/1297
letracyclinbase, um einen isiedikamentverband zu erhalten.letracyclinebase to obtain an isiedicament dressing.
Sas in Beispiel 1 beschriebene Verfahren wird wiederholt, jedoch wird keine Polyäthylenfolie verwendet und die teigartige Klebstoffmasse direkt zwischen zu verklebenden Flächen aufgetragen.The method described in Example 1 is repeated, but no polyethylene film is used and the dough-like adhesive mass is applied directly between surfaces to be bonded.
Das in Beispiel 1 beschriebene Verfahren wird wiederholt, jedoch verwendet man statt 42 g Natriumcarboxymethylcellulose 39 g dieser Verbindung und 3 g Insulin, und erhält einen Medikament verband.The procedure described in Example 1 is repeated, except that 42 g of sodium carboxymethyl cellulose are used instead 39 g of this compound and 3 g of insulin, and receives a drug bandage.
Das in Beispiel 1 beschriebene Verfahren wird wiederholt, jedoch verwendet man anstelle von Polyisobutylen 22 g Saccharoseacetatisobutyrat und 33 g Natriumcarboxyeethylcellulose. Die erhaltene Klebstoffmasse kann dann direkt als Verband verwendet werden, oder man trägt vor dem Gebrauch, eine wasserunlösliche Polyäthylenfolie darauf auf.The procedure described in Example 1 is repeated, but using 22 g instead of polyisobutylene Sucrose acetate isobutyrate and 33 g sodium carboxyethyl cellulose. The adhesive mass obtained can then be used directly be used as a bandage, or worn before use, a water-insoluble polyethylene film on it.
Das in Beispiel 1 beschriebene Verfahren wird wiederholt, jedoch wird anstelle der Polyäthylenfolie eine Folie aus einem Fluoihalogenkohlenwasserst off polymer verwendet. Man erhält einen gut haftenden Klebstreifen. Bei Verwendung eines Papieretiketts.anstelle der Polyäthylenfolie·erhält man ein auf nassen Flächen gut haftendes Etikett. Gleich, gut haftende Streifen werden unter Verwendung von Zellglasfolie oder einer flexiblen Polyvinylchloridfolie anstelle der Polyäthylenfolie erhalten.The procedure described in Example 1 is repeated, but instead of the polyethylene film, a film is made a Fluoihalogenohlenwasserstoff polymer used. Man receives a well-adhering adhesive tape. If a paper label is used instead of the polyethylene film a label that adheres well to wet surfaces. As well as adhesive strips are made using cellulose film or a flexible polyvinyl chloride sheet instead of the Polyethylene film received.
909834/1297909834/1297
Eine Klebmasse wird aus folgenden Bestandteilen hergestellt: ifatriuincarboxymethylcelluloBe 40,0 gAn adhesive is made from the following components: ifatriuincarboxymethylcelluloBe 40.0 g
Pentaerythritester von hydriertem Kolophonium 20,0 gPentaerythritol ester of hydrogenated rosin 20.0 g
Sas Polyisobutylen, der Kautschuk und der Kolophoniumester werden vermischt, bis ein einheitliches Gemisch erhalten worden ist und anschliessend die Natriumoarboxymethylcelluloee zugesetzt und erneut gemischt, bis eine einheitliche Masse erhalten worden ist. Die teigartige Masse kann gemäss Beispiel 1 auf Klebstreifen aufgetragen werden.Sas polyisobutylene, the rubber and the rosin ester are mixed until a uniform mixture has been obtained and then the sodium oarboxymethylcellulose is added and mixed again until a uniform mass has been obtained. The dough-like mass can are applied according to Example 1 to adhesive tape.
hochpolymeres Polyoxyäthylen (Polyox N-3000) 37,Oghigh polymer polyoxyethylene (Polyox N-3000) 37, above
Die Polyisobutylene werden in einem geschlossenen Behälter in dem Chloroform gelöst,und nach deren vollständiger Lösung wird das Äthylenoxydpolymere, das Polyterpenharz und das Mineralöl zugesetzt und das Gemisch, bis zur einheitlichen Diepergierung der Komponenten gerührt. Eine schleiaige Masse wird erhalten, die zur Verklebung von Flächen z.B. durch Aufpinseln oder Aufwalzen aufgetragen werden kann.The polyisobutylenes are dissolved in the chloroform in a closed container, and after they are completely dissolved becomes the ethylene oxide polymer, the polyterpene resin and the Mineral oil is added and the mixture is stirred until the components are uniformly dispersed. A slimy mass is obtained, which can be applied for gluing surfaces, e.g. by brushing or rolling on.
909834/129 7909834/129 7
Ί569231Ί569231
— ο -- ο -
wird aus folgenden Stoffen hergestellt:is made from the following materials:
hochpolymere Polyoxyäthylen (Polyox N-750) 20,Oghigh polymer polyoxyethylene (Polyox N-750) 20, above
Polychloroprenkautschuk (Neoprene GRT) 20,0 g Methylenchlorid 600Polychloroprene rubber (Neoprene GRT) 20.0 g Methylene chloride 600
Die Bestandteile werden durch Lösen und Vermischen in einem geschlossenen Behälter bis zur Homogenität zu einer flüssigen Klebmasse verarbeitet.The ingredients become one by dissolving and mixing in a closed container until homogeneous processed liquid adhesive.
Eine für Verbände geeignete Klebmasse wird aus folgenden Stoffen hergestellt:An adhesive suitable for bandages is made up of the following Fabrics made:
Natriumalginat 10,0 g Traganth 8,0 gSodium alginate 10.0 g tragacanth 8.0 g
Das Diäthylamino-2,6~dimethylacetanilid, Natriumcarboxymethylcellulose, Natriumalginat und Traganth, die alle in Pulverform vorliegen, werden bis zur Homogenität vermischt, und das erhaltene Gemischvtofl zum Polyisobutylen in eine« Sigma-Mischer zugesetzt und vermischt, bis eine einheitliche Masse gebildet ist. Die Masse kann zu Platten ausgewalzt werden, die auf der einen Seite eine wasserfeste Unterlage und auf der anderen Seite ein ablösbares Schutzpapier tragen» Ib können auch beide Seiten mit einem ablösbaren Schutzpajpier bedeckt sein und dann eine für verschiedene ärztliche und zahnärztliche Zwecke geeignete Verbandmasse bilden.The diethylamino-2,6 ~ dimethylacetanilide, sodium carboxymethyl cellulose, sodium alginate and tragacanth, all in In powder form, are mixed until homogeneous, and the mixture obtained is added to the polyisobutylene in a Sigma mixer and mixed until a uniform mass is formed. The mass can be rolled out into plates that have a waterproof base on one side and on wear removable protective paper on the other side »Ib can also have a removable protective pajpier on both sides be covered and then form a dressing material suitable for various medical and dental purposes.
909834/1297909834/1297
156923t156923t
Eine zur Verwendung in einem Aerosol-Sprühbehälter geeignete Klebmasse wird,aus folgenden Stoffen hergestellt:One suitable for use in an aerosol spray container Adhesive is made from the following materials:
hochpolymeres Polyoxyäthylen (Polyox N-750) 20,0 ghigh polymer polyoxyethylene (Polyox N-750) 20.0 g
Polyterpenharz (Piccolyte S-115) 10,0 gPolyterpene resin (Piccolyte S-115) 10.0 g
Polyisobutylen (Vistonex LM MS) 10,0 gPolyisobutylene (Vistonex LM MS) 10.0 g
Butylkautschuk 8,0 gButyl rubber 8.0 g
Trichlorfluorraethan 200,0 gTrichlorofluoroethane 200.0 g
Diehlordifluormethan 200,0 gDiehlordifluoromethan 200.0 g
Die Bestandteile werden durch Vermischen in einem geschlossenen Behälter bis zur Homogenität gelöst und dispergiert und eine Klebmasse erhalten, die in Druckbehälter für Aerosole abgefüllt werden kann.The ingredients are mixed in a closed Container dissolved and dispersed until homogeneous and an adhesive obtained in pressure containers for aerosols can be bottled.
Beispiel 18
Eine Klebmasse wird aus -folgenden Stoffen hergestellt:Example 18
An adhesive is made from the following substances:
Natriumearboxymethylcellulose 40,0 gSodium arboxymethyl cellulose 40.0 g
Pentaerythritester von hydriertem KolophoniumPentaerythritol ester of hydrogenated rosin
Naturkautschuk . kurzfaseriger Asbest Titandioxyd-PigmentNatural rubber. short-fiber asbestos titanium dioxide pigment
Methyl-1-hydroxybenzoat (Konservierungsmittel) Methyl 1-hydroxybenzoate (preservative)
Polyisobutylen (Vistonex LM MH)Polyisobutylene (Vistonex LM MH)
Das Polyisobutylen wird in einen Sigma-tfischer eingefüllt,und dan übrigen werden Bestandteile zugesetzt und bis. zur Homogenität bei etwa 93° 0 vermischt. Die erhaltene Klebmasse wird zu Platten ausgewalzt. Eine Seite der Platte wird mit ablösbarem Schutzpapier und die andere Seite mit einer Metalloder Kunststoffolie abgedeckt. Das erhaltene Klebpflaster kann nach dem Zerschneiden auf die geeignete Grosse als selbstfclebendes Dichtungsmaterial für Lecks z.B. in BootenThe polyisobutylene is poured into a Sigma-tfischer, and then remaining ingredients are added and up. mixed to homogeneity at about 93 ° 0. The adhesive obtained is rolled into plates. One side of the plate is covered with removable protective paper and the other side with a metal or Plastic film covered. The adhesive plaster obtained can after cutting to the appropriate size as self-adhesive sealing material for leaks e.g. in boats
909834/1297909834/1297
oder Schiffen, Wänden oder Rohrleitungen verwendet werden.or ships, walls or pipelines.
Beiapiel 19 Eine Klebmasse wird aus folgenden Stoffen hergestellt: Example 19 An adhesive is made from the following substances:
hoohpolymeres Folyoxyäthylen (Polyox N-3000)high-polymer polyoxyethylene (Polyox N-3000)
HeptanHeptane
Methylenchlorid und Heptan werden in einen geschlossenen Behälter gegeben, die anderen Bestandteile zugesetzt und bis zur Homogenität des Gemisches miteinander vermischt. Die erhaltene kolloide Dispersion kann anschliessend auf Zellglasfolie oder einem durchsichtigen Kunststoffilm aufgebracht und das Lösungsmittel verdampft werden, wobei ein druckempfindlicher Klebestreifen erhalten wird.Methylene chloride and heptane are placed in a closed container, the other ingredients are added and up mixed together for homogeneity of the mixture. The colloidal dispersion obtained can then be applied to cellulose film or a transparent plastic film and evaporating the solvent to obtain a pressure-sensitive adhesive tape.
Die gemäss Beispiel 19 hergestellte Klebmasse wird auf eine flexible Unterlage, wie sie für medizinische Heftpflaster verwendet wird, aufgebracht und die freie Klebmassenschicht mit ablösbarem Schutzpapier abgedeckt. Das Heftpflaster ist zur Verwendung bei Schwimmern und anderen Sportlern, bei Fischen, im Wasser lebenden'Säugetieren oder bei Bäumen geeignet, wobei das .Pflaster grosser Feuchtigkeit ausgesetzt ist.The adhesive produced according to Example 19 is applied to a flexible base, as it is used for medical adhesive plaster, applied and the free adhesive layer covered with removable protective paper. The adhesive plaster is for use by swimmers and other athletes Fish, aquatic mammals or trees, where the patch is exposed to high levels of moisture.
- Patentansprüche -- patent claims -
909834/1297909834/1297
Claims (5)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31016263A | 1963-09-19 | 1963-09-19 | |
| US330271A US3339546A (en) | 1963-12-13 | 1963-12-13 | Bandage for adhering to moist surfaces |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1569231A1 true DE1569231A1 (en) | 1969-08-21 |
Family
ID=26977241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19641569231 Pending DE1569231A1 (en) | 1963-09-19 | 1964-09-18 | Adhesive |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE653252A (en) |
| CH (1) | CH437633A (en) |
| DE (1) | DE1569231A1 (en) |
| DK (1) | DK109225C (en) |
| ES (1) | ES304156A1 (en) |
| FR (1) | FR1505318A (en) |
| GB (1) | GB1088992A (en) |
| SE (1) | SE311979B (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2631277A1 (en) * | 1975-07-28 | 1977-02-17 | Squibb & Sons Inc | MEDICAL DRESSING MATERIAL AND METHOD FOR MANUFACTURING IT |
| DE2557566A1 (en) * | 1975-12-20 | 1977-06-30 | Beiersdorf Ag | SELF-ADHESIVE |
| EP0663235A4 (en) * | 1993-07-30 | 1996-11-20 | Takiron Co | Phase separated membrane. |
| WO1999013913A3 (en) * | 1997-09-15 | 1999-06-03 | Southern Biosystems Inc | High viscosity liquid controlled delivery system as a device |
| EP0671176B1 (en) * | 1993-09-30 | 2001-06-06 | Takiron Co. Ltd. | Percutaneously absorbable preparation |
| US6413536B1 (en) | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
| US7833543B2 (en) | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
| US8133507B2 (en) | 2002-12-13 | 2012-03-13 | Durect Corporation | Oral drug delivery system |
| US8153661B2 (en) | 2004-09-17 | 2012-04-10 | Durect Corporation | Controlled delivery system |
| US8415401B2 (en) | 2007-12-06 | 2013-04-09 | Durect Corporation | Oral pharmaceutical dosage forms |
| US8956644B2 (en) | 2006-11-03 | 2015-02-17 | Durect Corporation | Transdermal delivery systems |
| US9555113B2 (en) | 2013-03-15 | 2017-01-31 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US9616055B2 (en) | 2008-11-03 | 2017-04-11 | Durect Corporation | Oral pharmaceutical dosage forms |
| US10471001B2 (en) | 2002-06-25 | 2019-11-12 | Durect Corporation | Short duration depot formulations |
| US11083796B2 (en) | 2005-07-26 | 2021-08-10 | Durect Corporation | Peroxide removal from drug delivery vehicle |
| US11771624B2 (en) | 2020-01-13 | 2023-10-03 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
| US12274794B2 (en) | 2016-07-06 | 2025-04-15 | Orient Pharma Co., Ltd. | Oral dosage form with drug composition, barrier layer and drug layer |
| US12433877B2 (en) | 2021-01-12 | 2025-10-07 | Durect Corporation | Sustained release drug delivery systems and related methods |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO134790C (en) * | 1968-07-09 | 1984-03-22 | Smith & Nephew | Kleber ,; PRESSURE SENSITIVE, WATERPUME-PERMEABLE PRODUCT FOR SKIN USE BY HUMANS. |
| GB1549756A (en) * | 1977-03-10 | 1979-08-08 | Everett W | Wound irrigating device |
| NZ186585A (en) * | 1977-03-30 | 1981-03-16 | Kingsdown Medical Consultants | Coupling for joining pad or dressing to an ostomy bag |
| GB1576522A (en) * | 1977-05-24 | 1980-10-08 | Colorplast International A S | Sealing material for ostomy devices |
| GB2038661B (en) | 1978-11-20 | 1982-12-01 | Searle & Co | Surgical sealant composition |
| US4342745A (en) * | 1979-05-31 | 1982-08-03 | Zyma S.A. | Use of polyvinyl alcohols for the treatment of lesions |
| US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
| US4438139A (en) | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
| US4292972A (en) * | 1980-07-09 | 1981-10-06 | E. R. Squibb & Sons, Inc. | Lyophilized hydrocolloio foam |
| US4591501A (en) * | 1981-04-13 | 1986-05-27 | Seton Company | Cosmetic and pharmaceutical sheet material containing polypeptides |
| US4585797A (en) * | 1981-04-13 | 1986-04-29 | Seton Company | Cosmetic and pharmaceutical sheet material containing polypeptides |
| US4460562A (en) * | 1982-01-06 | 1984-07-17 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing propranolol |
| US5175246A (en) * | 1992-01-22 | 1992-12-29 | University Of Akron, The | Medical grade adhesives and their preparation |
| JP3310371B2 (en) * | 1993-02-01 | 2002-08-05 | アルケア株式会社 | Skin protection material composition |
| ATE238402T1 (en) | 1997-08-29 | 2003-05-15 | Avery Dennison Corp | BIOLOGICAL LIQUID ABSORBING PRESSURE SENSITIVE ADHESIVES |
| GB9719711D0 (en) | 1997-09-16 | 1997-11-19 | Avery Dennison Corp | Hydrocolloid pressure sensitive adhesive |
| KR102085683B1 (en) | 2012-12-07 | 2020-03-06 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | Silicone gel adhesive with hydrophilic and antimicrobial properties |
| CN115737888B (en) * | 2022-03-22 | 2023-12-15 | 德晟康(苏州)生物科技有限公司 | Composite protein slow-release hydrocolloid application |
-
1964
- 1964-09-09 GB GB36965/64A patent/GB1088992A/en not_active Expired
- 1964-09-11 CH CH1189264A patent/CH437633A/en unknown
- 1964-09-16 SE SE11099/64A patent/SE311979B/xx unknown
- 1964-09-17 FR FR988381A patent/FR1505318A/en not_active Expired
- 1964-09-18 BE BE653252A patent/BE653252A/xx unknown
- 1964-09-18 DK DK461064AA patent/DK109225C/en active
- 1964-09-18 ES ES0304156A patent/ES304156A1/en not_active Expired
- 1964-09-18 DE DE19641569231 patent/DE1569231A1/en active Pending
Cited By (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2631277A1 (en) * | 1975-07-28 | 1977-02-17 | Squibb & Sons Inc | MEDICAL DRESSING MATERIAL AND METHOD FOR MANUFACTURING IT |
| DE2557566A1 (en) * | 1975-12-20 | 1977-06-30 | Beiersdorf Ag | SELF-ADHESIVE |
| EP0663235A4 (en) * | 1993-07-30 | 1996-11-20 | Takiron Co | Phase separated membrane. |
| EP0671176B1 (en) * | 1993-09-30 | 2001-06-06 | Takiron Co. Ltd. | Percutaneously absorbable preparation |
| US5968542A (en) * | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
| US6413536B1 (en) | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
| US7053209B1 (en) | 1995-06-07 | 2006-05-30 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
| US7833543B2 (en) | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
| WO1999013913A3 (en) * | 1997-09-15 | 1999-06-03 | Southern Biosystems Inc | High viscosity liquid controlled delivery system as a device |
| US11179326B2 (en) | 2002-06-25 | 2021-11-23 | Durect Corporation | Short duration depot formulations |
| US10471001B2 (en) | 2002-06-25 | 2019-11-12 | Durect Corporation | Short duration depot formulations |
| US10471002B2 (en) | 2002-06-25 | 2019-11-12 | Durect Corporation | Short duration depot formulations |
| US8168217B2 (en) | 2002-12-13 | 2012-05-01 | Durect Corporation | Oral drug delivery system |
| US8951556B2 (en) | 2002-12-13 | 2015-02-10 | Durect Corporation | Oral drug delivery system |
| US9918982B2 (en) | 2002-12-13 | 2018-03-20 | Durect Corporation | Oral drug delivery system |
| US8354124B2 (en) | 2002-12-13 | 2013-01-15 | Durect Corporation | Oral drug delivery system |
| US8133507B2 (en) | 2002-12-13 | 2012-03-13 | Durect Corporation | Oral drug delivery system |
| US8420120B2 (en) | 2002-12-13 | 2013-04-16 | Durect Corporation | Oral drug delivery system |
| US8147870B2 (en) | 2002-12-13 | 2012-04-03 | Durect Corporation | Oral drug delivery system |
| US9517271B2 (en) | 2002-12-13 | 2016-12-13 | Durect Corporation | Oral drug delivery system |
| US8945614B2 (en) | 2002-12-13 | 2015-02-03 | Durect Corporation | Oral drug delivery system |
| US8153152B2 (en) | 2002-12-13 | 2012-04-10 | Durect Corporation | Oral drug delivery system |
| US9233160B2 (en) | 2002-12-13 | 2016-01-12 | Durect Corporation | Oral drug delivery system |
| US8974821B2 (en) | 2002-12-13 | 2015-03-10 | Durect Corporation | Oral drug delivery system |
| US8153661B2 (en) | 2004-09-17 | 2012-04-10 | Durect Corporation | Controlled delivery system |
| US8846072B2 (en) | 2004-09-17 | 2014-09-30 | Durect Corporation | Controlled delivery system |
| US8753665B2 (en) | 2004-09-17 | 2014-06-17 | Durect Corporation | Controlled delivery system |
| US8153149B2 (en) | 2004-09-17 | 2012-04-10 | Durect Corporation | Controlled delivery system |
| US11083796B2 (en) | 2005-07-26 | 2021-08-10 | Durect Corporation | Peroxide removal from drug delivery vehicle |
| US8956644B2 (en) | 2006-11-03 | 2015-02-17 | Durect Corporation | Transdermal delivery systems |
| US8415401B2 (en) | 2007-12-06 | 2013-04-09 | Durect Corporation | Oral pharmaceutical dosage forms |
| US9592204B2 (en) | 2007-12-06 | 2017-03-14 | Durect Corporation | Oral pharmaceutical dosage forms |
| US10206883B2 (en) | 2007-12-06 | 2019-02-19 | Durect Corporation | Oral pharamaceutical dosage forms |
| US9655861B2 (en) | 2007-12-06 | 2017-05-23 | Durect Corporation | Oral pharmaceutical dosage forms |
| US10328068B2 (en) | 2008-11-03 | 2019-06-25 | Durect Corporation | Oral pharmaceutical dosage forms |
| US9884056B2 (en) | 2008-11-03 | 2018-02-06 | Durect Corporation | Oral pharmaceutical dosage forms |
| US9616055B2 (en) | 2008-11-03 | 2017-04-11 | Durect Corporation | Oral pharmaceutical dosage forms |
| US10300142B2 (en) | 2013-03-15 | 2019-05-28 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US9907851B2 (en) | 2013-03-15 | 2018-03-06 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US9572885B2 (en) | 2013-03-15 | 2017-02-21 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US9555113B2 (en) | 2013-03-15 | 2017-01-31 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US9855333B2 (en) | 2013-03-15 | 2018-01-02 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US12274794B2 (en) | 2016-07-06 | 2025-04-15 | Orient Pharma Co., Ltd. | Oral dosage form with drug composition, barrier layer and drug layer |
| US11771624B2 (en) | 2020-01-13 | 2023-10-03 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
| US12433877B2 (en) | 2021-01-12 | 2025-10-07 | Durect Corporation | Sustained release drug delivery systems and related methods |
Also Published As
| Publication number | Publication date |
|---|---|
| FR1505318A (en) | 1967-12-15 |
| ES304156A1 (en) | 1965-03-01 |
| CH437633A (en) | 1967-06-15 |
| BE653252A (en) | 1965-01-18 |
| DK109225C (en) | 1968-04-01 |
| SE311979B (en) | 1969-06-30 |
| GB1088992A (en) | 1967-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1569231A1 (en) | Adhesive | |
| DE3148097A1 (en) | WATERPROOF ELASTIC SKIN COVER | |
| DE69326418T2 (en) | Medical, flood-absorbent polymers for wound dressings and medical bandages | |
| AT392796B (en) | ADHESIVE ADHESIVES | |
| DE2954239C2 (en) | ||
| DE2631277A1 (en) | MEDICAL DRESSING MATERIAL AND METHOD FOR MANUFACTURING IT | |
| DE2919923C2 (en) | ||
| DE69011192T2 (en) | Process for the production of a permeable adhesive tape. | |
| CH639678A5 (en) | ADHESIVE MIXTURE AND THEIR USE. | |
| DE2628890A1 (en) | SHAPED BODIES, IN PARTICULAR MONTHLY BANDS, FOR ABSORBING LIQUIDS | |
| DE2320197C3 (en) | Process for the production of web-like or sheet-like materials with a carrier with a polyurethane self-adhesive layer | |
| DE2100853A1 (en) | Flat pressure sensitive adhesives | |
| CH672598A5 (en) | ||
| DD293835A5 (en) | CONTINUOUS, PRESSURE-SENSITIVE SKIN-ADHESIVE | |
| DE19724456A1 (en) | Medicinal blend composition with long-lasting drug delivery option | |
| CH639110A5 (en) | Adhesive preparation, and medical auxiliaries containing the former | |
| DE855297C (en) | Protective overlay for adhesive rubber sheets | |
| DE2848977A1 (en) | PRESSURE SENSITIVE ADHESIVE TAPE | |
| DE4314834A1 (en) | Film-based bandaging material | |
| DE3149895A1 (en) | "SKIN PROTECTION FILM" | |
| CH279767A (en) | Association. | |
| DE1809124A1 (en) | Adhesive comp | |
| DE69523443T2 (en) | MATERIAL FOR WOUND COVERING | |
| DE69503898T2 (en) | PRESSURE-SENSITIVE HYDROPHILIC COMPOSITE ADHESIVE AND PRODUCTION METHOD | |
| EP0473918A1 (en) | Film-basis dressing |